High versus standard dose vancomycin for osteomyelitis

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 10, 2004, Pages 712-717

  El Amari, Emmanuelle Boffi ^a   Vuagnat, Albert ^b   Stern, Richard ^a   Assal, Mathieu ^a   Denormandie, Philippe ^c   Hoffmeyer, Pierre ^a   Bernard, Louis ^a,c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b St Michel Hospital   (France)

^c RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INFUSION; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FOLLOW UP; GRAM POSITIVE COCCI; HUMAN; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUTROPENIA; OPTIMAL DRUG DOSE; OSTEOMYELITIS; PHLEBITIS; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

EID: 7944221429     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Lew DP, Waldvogel FA. Osteomyelitis. New Eng J Med 1997; 336: 999-1007.
2. Wysocki M, Delatour F, Faurisson F, Rauss A, Pean Y, Misset B, et al. Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicentre randomized study. Antimicrob Agents Chemother 2001; 45: 2460-7.
3. Barois A, Estournet B, Moranne JB, Piliot J, Chabenat C, Bataille J. Ventricular staphylococcal infections. Treatment with vancomycin by continuous venous infusion. Presse Med 1986; 15: 1805-8.
4. Brinquin L, Rousseau JM, Boulesteix G, Diraison Y, Bonsignour JP. Continuous infusion of vancomycin in post-neurosurgical staphylococcal meningitis in adults. Presse Med 1993; 22: 1815-7.
5. Bernard E, Perbost I, Carles M, Michiels A, Carsenti-Etesse H, Chichmanian R M, Delarmonica P. Efficacy and safety of vancomycin constant-rate infusion in the treatment of chronic Gram-positive bone and joint infections. Clin Microbiol Infect 1997; 3: 440-6.
6. Bernard L, El H, Pron B, Lotthe A, Gleizes V, Signoret F, et al. Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost. J Clin Pharm Ther 2001; 26: 445-51.
7. Bernard L, Vaudaux P, Vuagnat A, Stern R, Rohner P, Pittet D, et al. and the Osteomyelitis Study Group. Effect of vancomycin therapy for osteomyelitis on colonization by methicillin-resistant Staphylococcus aureus: lack of emergence of glycopeptide resistance. Infect Control Hosp Epidemiol 2003; 24: 650-4.
8. Ariza J, Pujol M, Cabo J, Pena C, Fernandez N, Linares J, et al. Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogenous resistance to vancomycin. Lancet 1999; 353: 1587-8.
9. Elting L, Rubinstein E, Kurtin D, Rolston K, Fangtang J, Martin C, et al. Mississippi mud in the 1990s. Risk and outcome of vancomycin-associated toxicity in general oncology practice. Cancer 1998; 12: 2597-607.
10. National Committee for Laboratory Standards. Performance standards for antimicrobial susceptibility: approved standard. Approved Standard M100-S9. NCCLS, 1999; Wayne, PA, USA.
11. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
12. Massias L, Dubois C, de Lentdecker P, Brodaty O, Fischler M, Farinotti R. Penetration of vancomycin in uninfected sternal bone. Antimicrob Agents Chemother 1992; 36: 2539-41.
13. Drago L, de Vecchi E, Fassina MC, Gismondo MR. Serum and bone concentrations of teicoplanin and vancomycin: study in an animal model. Drugs Exp Clin Res 1998; 24: 185-90.
14. James JK, Palmer SM, Levine DP, Rybak MJ. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented Gram-positive infections. Antimicrob Agents Chemother 1996; 40: 696-700.
15. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopaedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998; 279: 1537-41.
16. Drancourt M, Stein A, Argenson JN, Roiron R, Groulier P, Raoult D. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J Antimicrob Chemother 1997; 39: 235-40.
17. Wai AO, Lo AM, Abdo A, Marra F. Vancomycin-induced acute interstitial nephritis. Ann Pharmacother 1998; 32: 1160-4.
18. Cohen E, Dadashev A, Drucker M, Samra Z, Rubinstein E, Garry M. Once daily versus twice-daily intravenous administration of vancomycin for infections in hospitalized patients. J Antimicrob Chemother 2002; 49: 155-60.